MLA controls any sales and subsequently trials of burette in Australia. ALT recieves a royalty. Now I think someone mentioned approx $20k in the last Qrtly. I dont know what margin royalty is paid (commercially confidential) but lets say 10% means sales equal $200k per qrtly., which in my opinion means the rollout and sales are progressing quite nicely. If it is yearly then that isnt bad either, considering the budgetry constraints of both QLD & NSW Hospitals.
Maybe an email to MLA also?
Cheers
T1
ALT Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held